Site icon news.soban.in

Novo Nordisk sues Dr. Reddy’s over Ozempic trademark(Soban News)

With semaglutide off-patent, a flood of low-cost generics is shifting the fight from molecules to brand names in India’s fast-growing weight-loss market

​With semaglutide off-patent, a flood of low-cost generics is shifting the fight from molecules to brand names in India’s fast-growing weight-loss market by Soban News (international And National News)

Exit mobile version